PRESS RELEASE

Q4 2025 — Press release

Q4 2025PDF · 17 pages774 KB
PRESS RELEASE
Philip Morris International Reports 2025 Fourth-Quarter & Full-Year Results;
Delivers Full Year 2025 Reported Diluted EPS of $7.26 compared to $4.52 in 2024 and Adjusted Diluted
EPS of $7.54, Representing Growth of 14.8%, and 14.2% on a Currency-Neutral Basis;
Provides 2026 - 2028 Growth Targets
STAMFORD, CT, February 6, 2026 – Philip Morris International Inc. (PMI) (NYSE: PM) today announces its 2025
fourth quarter results.1
"We achieved another remarkable year of results in 2025, with a fifth consecutive year of volume growth, net
revenues surpassing $40 billion, including close to $17 billion from our smoke-free business, and very good
operating margin expansion," said Jacek Olczak, Group CEO PMI.
"With excellent results in 2024 and 2025, we have delivered our three-year CAGR targets on operating income
and EPS in just two years. With another strong performance expected in 2026, we are on track to outperform
our 2024-2026 growth algorithm. This again demonstrates our ability to create sustainable value for our
shareholders as we renew our growth targets for 2026-2028."
Results Highlights
• Smoke-free business (SFB): Our smoke-free business delivered a strong performance, with full-year
shipment volumes up by 12.8%, net revenues growing by 15.0% (14.1% organically) and gross profit
increasing by 20.3% (18.7% organically). Our smoke-free business accounted for 41.5% of our total net
revenues, and nearly 43% of total gross profit (up by 2.8pp and 3.2pp respectively vs. full-year 2024). Our
smoke-free products (SFP) are now available in 106 markets, with over 43 million estimated adult consumers
(up by around 4.5 million versus December 2024). In the fourth quarter, we delivered 12.0% net revenue
growth (8.6% organically), 12.2% gross profit growth (8.3% organically) while achieving a key milestone with
over 50% of net revenues generated by the smoke-free business in 3 of our 4 regions. On full-year basis, we
reached the same milestone in 27 markets, including 8 markets where we exceeded 75%.
• Heat-not-burn SFP: IQOS continued to drive the growth of the global category, where PMI holds
approximately 76% volume share. We strengthened the overall position of IQOS (gaining 1pp of the combined
cigarette and HTU industry volumes in the fourth quarter to reach 9.6%) as the second largest nicotine ‘brand’
in markets where present, with the #1 volume share position in 13 markets. HTU adjusted in-market sales
(IMS) volume growth, which excludes the net impact of estimated distributor and wholesaler inventory
movements, accelerated to 12% in the fourth quarter and increased by an estimated 10.5% for the full-year,
broadly in line with shipment growth.
• In Japan, PMI HTU adjusted IMS grew by an estimated 7.0% for the full year and 5.8% in the fourth quarter.
IQOS continues to hold close to 70% of heat-not-burn category volume, notwithstanding intensifying
competition. IQOS HTU adjusted market share of total nicotine increased by 2.0pp to 32.6% in the fourth
1 Explanation of PMI's use of non-GAAP measures cited in this document and reconciliations to the most directly comparable U.S. GAAP measures can be found
in the “Non-GAAP Measures, Glossary and Explanatory Notes” section of this release, in Exhibit 99.2 to the company's Form 8-K dated February 6, 2026, and
here.

-- 1 of 17 --

quarter. In December, the overall HTU category exceeded 50% of total nicotine offtake share at the national
level, including 19 out of 20 major cities and 16 prefectures.
• In Europe, with continuous brand equity investment and innovation, IQOS HTU adjusted IMS grew by an
estimated 8.6% for the full year with an acceleration in the fourth quarter to 10.3% and IQOS HTU adjusted
market share up by 1.5pp to 12.0%. Another year of dynamic adjusted IMS growth was led by Italy's return
to double-digit performance, which was also delivered in many other markets, notably Germany, Greece,
Romania and Spain.
• Outside Europe and Japan, adjusted IMS grew strongly in the fourth quarter and offtake share increased in
key cities across the globe, including Mexico City, Jakarta, Riyadh, Kuala Lumpur, Cairo and Manila. In
Taiwan, the recent launch of IQOS delivered very promising early results.
• Oral SFP: Full-year shipment volume increased by 18.5% (up 7.3% in Q4) in pouch or pouch equivalents,
fueled by nicotine pouches, which grew by nearly 37% in the U.S., and over 35% in international markets,
despite some snus volume declines in the Nordics.
• In the U.S., nicotine pouches account for a high single-digit percentage of total industry volumes and remain
the fastest growing nicotine category. ZYN, with a premium price positioning, continued to lead the category
with around two-thirds value share in 2025. Supported by a wide range of commercial activities to further
enhance the equity and presence of the brand, ZYN shipment volume in the fourth quarter reached 196
million cans, an increase of over 19%, whilst offtake volume grew 23% as estimated by Nielsen. Full-year
ZYN shipment volumes reached 794 million cans.
• The international nicotine pouch business continues to expand, with ZYN now available in 55 markets and
growth fueled by strong market share gains of this dynamically growing category. Our focus remains on
switching legal-age smokers with a relevant product portfolio, including 1.5mg variants which are now
available in around two thirds of ZYN markets.
• E-vapor SFP: VEEV continued to accelerate its increasingly profitable growth, and is now available in 47
markets. Shipment volumes more than doubled on a full-year basis, notably driven by Europe and Indonesia.
Within the closed pods segment, VEEV holds the #1 volume share position in 8 markets, and is gaining
significant market share, sourcing primarily from legal-age consumers of other vaping products and adult
smokers. PMI remains committed to building and commercializing the brand in a focused, responsible and
profitable manner.
• Combustibles: Notwithstanding expected lower volumes, full-year net revenues grew by 2.5% (1.8%
organically) driven by strong pricing, partly offset by geographic mix. Together with productivity improvements,
this resulted in gross profit growth of 5.2% (4.4% organically). In the fourth quarter net revenues grew by 3.2%
(up 0.3% organically) with gross profit up by 5.5% (2.8% organically) and Marlboro reaching a record high
11.0% category share. Our overall cigarette category share was slightly lower for the full-year, predominantly
due to Turkey.
• Dividend: Declared regular quarterly dividend of $1.47 per share, or an annualized $5.88 per share.
- 2 -

-- 2 of 17 --

Full-Year 2025 Performance Highlights
Total PMI SFP HTU Oral
SFP E-vapor2 Cigarettes
Total Shipment Volume
(units bn) 786.5 179.1 155.1 20.7 3.3 607.4
vs. FY 2024 1.4% 12.8% 11.0% 18.5% +100% (1.5)%
PMI Smoke-Free
Business Combustibles
Net Revenues ($ bn) $40.6 $16.9 $23.8
reported vs. FY 2024 7.3% 15.0% 2.5%
organic vs. FY 2024 6.5% 14.1% 1.8%
Gross Profit ($ bn) $27.3 $11.7 $15.6
reported vs. FY 2024 11.1% 20.3% 5.2%
organic vs. FY 2024 10.1% 18.7% 4.4%
Operating Income ($ bn) $14.9
reported vs. FY 2024 11.1%
organic vs. FY 2024 10.6%
Reported
Diluted
EPS
Adjusting
Items3
Adjusted
Diluted
EPS
Currency
Impact
Adj. Diluted
EPS ex.
Currency
EPS $7.26 $(0.28) $7.54 $0.04 $7.50
vs. FY 2024 60.6% 14.8% 14.2%
Fourth-Quarter 2025 Performance Highlights
Total PMI SFP HTU Oral
SFP E-vapor2 Cigarettes
Total Shipment Volume
(units bn) 193.8 44.3 38.4 5.0 1.0 149.4
vs. Q4 2024 0.1% 8.5% 7.5% 7.3% 91.4% (2.2)%
PMI Smoke-Free
Business Combustibles
Net Revenues ($ bn) $10.4 $4.4 $6.0
reported vs. Q4 2024 6.8% 12.0% 3.2%
organic vs. Q4 2024 3.7% 8.6% 0.3%
Gross Profit ($ bn) $6.8 $2.9 $3.9
reported vs. Q4 2024 8.3% 12.2% 5.5%
organic vs. Q4 2024 5.1% 8.3% 2.8%
Operating Income ($ bn) $3.4
reported vs. Q4 2024 3.5%
organic vs. Q4 2024 4.5%
Reported
Diluted
EPS
Adjusting
Items3
Adjusted
Diluted
EPS
Currency
Impact
Adj. Diluted
EPS ex.
Currency
EPS $1.37 $(0.33) $1.70 $0.01 $1.69
vs. Q4 2024 +100% 9.7% 9.0%
- 3 -
2 One milliliter of e-vapor liquid equivalent to 10 units; 2024 volume of e-vapor in billions of units: Q1 0.3, Q2 0.4, Q3 0.5, Q4 0.5
3 For a list of adjusting items refer to additional information section of this release
Note: Sums might not foot to total due to rounding.

-- 3 of 17 --

2026 Full-Year Forecast
Full-Year
2026
Forecast 2025 Growth
Reported Diluted EPS $7.87 - $8.02 $ 7.26
Adjustments:
Restructuring charges(1) — 0.14
Impairment of goodwill and other intangibles — 0.03
Amortization of intangibles 0.51 0.50
Germany excise tax classification litigation charge — 0.10
RBH (Canada) Plan Implementation, including dividend
income, net — (0.10)
Impairment of Wellness business related equity
investment — 0.09
Loss on expected sale of consumer accessories and
other businesses — 0.06
Income tax impact associated with Swedish Match AB
financing — (0.25)
Fair value adjustment for equity security investments — (0.18)
Tax items — (0.11)
Total Adjustments 0.51 0.28
Adjusted Diluted EPS $8.38 - $8.53 $ 7.54 11.1% - 13.1%
Less: Currency 0.27
Adjusted Diluted EPS, excluding currency $8.11 - $8.26 $ 7.54 7.5% - 9.5%
(1) 2025 amount reflects pre-tax restructuring charges of $241 million ($222 million net of income tax) with respect to manufacturing footprint optimization in Germany
Reported diluted EPS is forecast to be in a range of $7.87 to $8.02, at prevailing exchange rates, versus
reported diluted EPS of $7.26 in 2025. Excluding a total 2026 adjustment of $0.51 per share, this forecast
represents a projected increase of 11.1% to 13.1% versus adjusted diluted EPS of $7.54 in 2025. Also excluding
a favorable currency impact of $0.27, at prevailing exchange rates, this forecast represents a projected increase
of 7.5% to 9.5% versus adjusted diluted EPS of $7.54 in 2025, as outlined in the above table.
2026 Full-Year Forecast Assumptions
This forecast assumes:
• An estimated total international industry volume decline of around 2% for cigarettes and HTUs, excluding
China and the U.S.;
• Broadly stable total PMI cigarette and SFP shipment volume, with high-single digit SFP shipment volume
growth, and a cigarette shipment volume decline of around 3%, including the impact of weaker industry
volume in India and Mexico, and the ongoing recovery of our business in Turkey;
• Net revenue growth of 5% to 7% on an organic basis;
• Organic operating income growth of 7% to 9%;
• Full-year amortization of acquired intangibles of $0.51 per share;
• Broadly stable net financing costs;
• An effective tax rate, excluding discrete tax events, of around 21.5%;
• Operating cash flow around $13.5 billion at prevailing exchange rates, subject to year-end working capital
requirements;
- 4 -

-- 4 of 17 --

• Capital expenditures of $1.4 to $1.6 billion, predominantly due to investments supporting the smoke-free
business;
• Further net debt to adjusted EBITDA ratio improvement as we target a ratio of close to 2.0x by the end of
2026, at prevailing exchange rates;
• No share repurchases; and
• First quarter adjusted diluted EPS of $1.80 to $1.85, including an estimated favorable currency impact of 14
cents at prevailing exchange rates.
Factors described in the Forward-Looking and Cautionary Statements section of this release represent
continuing risks to these projections.
2026 - 2028 Growth Targets
Following strong full-year results in 2024 and 2025 coupled with another strong performance expected in 2026,
we are on track to deliver at or above the top end of our 2024 to 2026 compound annual growth ranges
announced on September 28th, 2023.
Today, the company provides 2026 to 2028 compound annual growth targets of:
– 6% to 8% for net revenues, on an organic basis, with SFP volume growth of high single-digit to low-
teens driving total shipment volume growth;
– 8% to 10% for operating income, on an organic basis; and
– 9% to 11% for adjusted diluted EPS, excluding currency, assuming current corporate income tax rates
and no share repurchases.
New Segment Reporting
With our smoke-free business now operating at scale across our regions, including substantial growth from our
U.S. business, PMI has implemented an evolved organizational model with two primary business units:
International and U.S. The updated organizational structure is designed to enhance our agility and to support our
journey to become a smoke-free company under the leadership of Jacek Olczak, Group CEO PMI. This change
was implemented effective January 1, 2026, and as a result PMI realigned its reportable segments accordingly.
The four geographic segments have been replaced with three new reportable segments: International Smoke-
Free, International Combustibles, and U.S. As of the first quarter of 2026, our reporting will reflect these
changes. The company plans to disclose select historical financial information for the 2023 to 2025 period based
on the new reportable segments before the end of the first quarter.
Conference Call
A conference call hosted by Jacek Olczak, Group CEO PMI, and Emmanuel Babeau, Group Chief Financial
Officer, will be webcast at 9:00 a.m., Eastern Time, on February 6, 2026. The webcast can be accessed here.
Investor Relations: Media:
Email: InvestorRelations@pmi.com Email: Corey.Henry@pmi.com
Stamford, CT: +1 (203) 905 2413 Stamford, CT: +1 (203) 905 2410
Lausanne: +41 582 424 500
- 5 -

-- 5 of 17 --

Fourth-Quarter 2025 Operating Review
Net Revenues
(in millions) Total PMI Europe SSEA, CIS &
MEA EA, AU &
PMI GTR Americas
2024 9,706 4,143 2,868 1,434 1,261
Price 285 158 240 13 (126)
Volume/Mix 73 54 (54) 1 72
Other (3) — (1) — (2)
Acquisitions & Divestitures (44) (44) — — —
Currency 345 287 56 (23) 25
2025 10,362 4,598 3,109 1,425 1,230
vs. Q4 2024 6.8% 11.0% 8.4% (0.6)% (2.5)%
Organic growth 3.7% 5.1% 6.5% 1.0% (4.4)%
Operating Income
(in millions) Total PMI Europe SSEA, CIS &
MEA EA, AU &
PMI GTR Americas
2024 3,259 1,750 806 574 129
Price 285 158 240 13 (126)
Volume/Mix 75 30 26 (46) 65
Cost/Other (289) (184) (60) 30 (75)
Acquisitions & Divestitures 3 3 — — —
Currency 40 153 (71) (57) 15
2025 3,373 1,910 941 514 8
vs. Q4 2024 3.5% 9.1% 16.7% (10.5)% (93.8)%
Adjustments* (349) (146) (4) (1) (198)
2025 Adjusted OI 3,722 2,056 944 515 207
vs. Q4 2024 5.8% 14.5% 16.5% (10.4)% (38.9)%
Organic growth 4.5% 5.8% 25.3% (0.5)% (43.4)%
2024 Adjusted OI Margin 36.3% 43.3% 28.2% 40.1% 26.9%
2025 Adjusted OI Margin 35.9% 44.7% 30.4% 36.1% 16.8%
vs. Q4 2024 (0.4)pp 1.4pp 2.2pp (4.0)pp (10.1)pp
Organic growth 0.3pp 0.3pp 5.0pp (0.6)pp (11.0)pp
(*) For a list of adjusting items refer to additional information section of this release or Schedule 9 in Exhibit 99.2 to the Form 8-K dated February 6, 2026.
HTU & Cigarette Shipments
(m units) Total PMI Europe SSEA, CIS &
MEA
EA, AU &
PMI GTR Americas
Heated Tobacco Units 38,398 16,289 9,236 12,681 192
vs. Q4 2024 7.5% 7.2% 9.6% 6.2% 28.0%
Cigarettes 149,426 36,891 85,640 10,219 16,676
vs. Q4 2024 (2.2)% (3.9)% (0.2)% (10.5)% (2.9)%
Total 187,824 53,180 94,876 22,900 16,868
vs. Q4 2024 (0.4)% (0.8)% 0.7% (2.0)% (2.6)%
Oral SFP Shipments
(m cans) Total PMI Europe SSEA, CIS &
MEA EA, AU &
PMI GTR Americas
Nicotine Pouches 217.0 11.7 6.3 1.0 198.0
vs. Q4 2024 18.1% (13.5)% 63.2% (22.7)% 19.9%
Snus 51.9 48.5 — 2.9 0.5
vs. Q4 2024 (10.8)% (15.6)% — — (32.6)%
Moist Snuff 31.2 — — — 31.2
vs. Q4 2024 (2.5)% — — — (2.5)%
Other Oral SFP 0.5 0.5 — — —
vs. Q4 2024 (22.6)% (22.6)% — — —
Total 300.5 60.7 6.3 3.9 229.7
vs. Q4 2024 9.5% (15.3)% 63.2% +100% 16.1%
Note: U.S. travel retail volumes of approximately 3.7m nicotine pouch cans recorded in Americas segment, financial impact recorded in EA, AU & PMI GTR
segment. No meaningful U.S. travel retail volumes in prior year. Refer to additional information section of this release for shipments in pouch or pouch
equivalents. "-" indicates volume below 0.1 million cans
- 6 -

-- 6 of 17 --

Total PMI
• Estimated industry volume (excluding China and the U.S.) for cigarettes and HTUs was broadly stable.
• PMI's shipment volume was flat with SFP volumes up by 8.5%, offset by a cigarette volume decline of
2.2%, predominantly driven by Europe and East Asia, Australia and PMI Global Travel Retail regions.
• Net revenues increased by 3.7% on an organic basis, mainly reflecting: a favorable pricing variance due
to higher combustible tobacco pricing; and favorable volume/mix driven by higher SFP volume,
notwithstanding lower volumes and unfavorable mix for cigarettes. As expected, the net revenue growth
rate was below the full-year, notably due to the shipment and phasing factors outlined previously.
• Adjusted operating income increased by 4.5% on an organic basis, mainly reflecting the same factors as
for net revenues, partly offset by higher marketing, administration and research costs.
Europe
• The estimated industry volume for cigarettes and HTUs decreased by 3.6% to 126.4 billion units, with a
5.0% decrease for cigarettes and continued HTU growth. Markets with notable decreases include
Poland (down by 15.4%), Ukraine (down by 16.5%), and France (down by 9.4%), partly offset by
Bulgaria (up by 8.3%), Germany (up by 1.7%), and Serbia (up by 6.4%).
• PMI's shipment volume decreased by 0.4% with cigarettes down by 3.9% and SFP up by 7.6%.
• Oral SFP shipments decreased, primarily driven by lower snus volume due to inventory movements.
Nicotine pouch shipment volume declined against a strong prior year comparator in the Nordics,
notwithstanding a very strong performance in other markets.
• Net revenues increased by 5.1% on an organic basis, reflecting: a favorable pricing variance
predominantly driven by higher combustible tobacco pricing; and favorable volume/mix driven by higher
smoke-free products volume, notwithstanding lower volumes and unfavorable mix for cigarettes.
• Adjusted operating income increased by 5.8% organically, mainly due to the same factors as for net
revenue, partly offset by higher marketing, administration and research costs.
SSEA, CIS & MEA
• The estimated industry volume for cigarettes and HTUs increased by 2.0% to 402.0 billion units, mainly
due to India (up by 11.1%) and Turkey (up by 4.6%), partly offset by Saudi Arabia (down by 11.3%).
• PMI's shipment volume increased by 0.8% with SFP up by 10.1% and cigarettes down by 0.2%.
• PMI's HTU adjusted IMS volume increased by an estimated 20.4% with strong growth across the region.
• Net revenues increased by 6.5% on an organic basis, primarily reflecting: a favorable pricing variance,
predominantly driven by higher combustible tobacco pricing; partly offset by unfavorable volume/mix
driven by unfavorable cigarette mix notably due to the below mentioned commercial model change in
Indonesia.
• A change in our commercial model for the below tier-one cigarette segment in Indonesia in the fourth
quarter of 2024 resulted in lower net revenue growth, with no meaningful impact on operating income.
• Adjusted operating income increased by 25.3% on an organic basis, mainly reflecting a favorable price
variance, predominantly driven by higher combustible tobacco pricing, partly offset by higher marketing,
administration and research costs.
- 7 -

-- 7 of 17 --

East Asia, Australia & PMI Global Travel Retail
• The estimated industry volume for cigarettes and HTUs, excluding China, decreased by 2.1% to 79.3
billion units, with HTU growth more than offset by decrease in cigarettes. Notable decreases in South
Korea (down by 8.0%) and Australia (down by 60.6%) were partly offset by Global Travel Retail (up by
5.6%) and Taiwan (up by 6.2%).
• PMI's shipment volume decreased by 1.7% with SFP up by 6.7% and cigarettes down by 10.5%.
• PMI's HTU adjusted in-market sales volume increased by an estimated 8.9%.
• Net revenues increased by 1.0% on an organic basis, primarily reflecting: a favorable price variance,
predominantly due to higher combustible tobacco pricing.
• Adjusted operating income decreased by 0.5% organically due to unfavorable volume/mix driven by
lower cigarette volume, partly offset by lower costs and favorable price variance.
Americas
• The estimated industry volume for cigarettes and HTUs, excluding the U.S., decreased by 1.9% to 49.1
billion units, driven by a decrease in the cigarette market. The decrease was mainly due to Canada
(down by 13.8%) and Argentina (down by 4.0%), partly offset by Brazil (up by 0.8%).
• PMI's shipment volume increased by 0.1% with SFP up by 15.6% and cigarettes down by 2.9%.
• Oral SFP shipments increased by 16.1% to 230 million cans, predominantly driven by ZYN nicotine
pouches in the U.S.
• Net revenues decreased by 4.4% organically, predominantly driven by the U.S., with an unfavorable
price comparison to low levels of ZYN promotional activity in the prior year, partly offset by favorable
volume/mix due to higher ZYN volume.
• Adjusted operating income decreased by 43.4% on an organic basis. While U.S. nicotine pouches
retained gross margins superior to our international SFP business, this decrease primarily reflects the
same factors as for net revenues; and higher marketing, administration and research costs, including
further investments in our U.S. capabilities and organization.
- 8 -

-- 8 of 17 --

Full-Year 2025 Operating Review
Net Revenues
(in millions) Total PMI Europe SSEA, CIS &
MEA EA, AU &
PMI GTR Americas
2024 37,878 15,690 11,261 6,393 4,534
Price 1,536 805 836 81 (186)
Volume/Mix 920 258 (146) 211 597
Other 23 — 36 — (13)
Acquisitions & Divestitures (170) (170) — — —
Currency 461 528 64 (53) (78)
2025 40,648 17,111 12,051 6,632 4,854
vs. FY 2024 7.3% 9.1% 7.0% 3.7% 7.1%
Organic growth 6.5% 6.8% 6.4% 4.6% 8.8%
Operating Income
(in millions) Total PMI Europe SSEA, CIS &
MEA EA, AU &
PMI GTR Americas
2024 13,402 6,547 3,429 2,878 548
Price 1,536 805 836 81 (186)
Volume/Mix 1,084 127 186 224 547
Cost/Other (1,371) (710) (326) 31 (366)
Acquisitions & Divestitures 87 56 31 — —
Currency 154 340 (60) (88) (38)
2025 14,892 7,165 4,096 3,126 505
vs. FY 2024 11.1% 9.4% 19.5% 8.6% (7.8)%
Adjustments* (1,536) (745) (15) (3) (774)
2025 Adjusted OI 16,428 7,909 4,111 3,129 1,279
vs. FY 2024 11.8% 13.3% 17.7% 8.6% (4.3)%
Organic growth 10.6% 8.5% 18.6% 11.7% (1.4)%
2024 Adjusted OI Margin 38.8% 44.5% 31.0% 45.1% 29.5%
2025 Adjusted OI Margin 40.4% 46.2% 34.1% 47.2% 26.3%
vs. FY 2024 1.6pp 1.7pp 3.1pp 2.1pp (3.2)pp
Organic growth 1.4pp 0.7pp 3.5pp 3.0pp (2.8)pp
(*) For a list of adjusting items refer to additional information section of this release or Schedule 10 in Exhibit 99.2 to the Form 8-K dated February 6, 2026.
HTU & Cigarette Shipments
(m units) Total PMI Europe SSEA, CIS &
MEA EA, AU &
PMI GTR Americas
Heated Tobacco Units 155,133 59,322 32,318 62,768 725
vs. FY 2024 11.0% 10.5% 13.1% 10.3% 16.6%
Cigarettes 607,367 153,758 347,293 45,709 60,607
vs. FY 2024 (1.5)% (5.5)% 0.7% (4.1)% (1.7)%
Total 762,500 213,080 379,611 108,477 61,332
vs. FY 2024 0.8% (1.5)% 1.7% 3.8% (1.5)%
Oral SFP Shipments
(m cans) Total PMI Europe SSEA, CIS &
MEA EA, AU &
PMI GTR Americas
Nicotine Pouches 879.6 54.2 22.9 4.7 797.9
vs. FY 2024 36.6% 11.0% 99.9% 99.2% 37.2%
Snus 227.9 212.0 — 13.4 2.4
vs. FY 2024 (4.9)% (10.4)% — — (18.1)%
Moist Snuff 129.8 — — — 129.8
vs. FY 2024 (3.5)% — — — (3.5)%
Other Oral SFP 2.6 2.6 — — —
vs. FY 2024 (22.9)% (23.4)% — — —
Total 1,240.0 268.8 22.9 18.1 930.2
vs. FY 2024 21.4% (6.9)% 99.9% +100% 29.4%
Note: U.S. travel retail volumes of approximately 11.9m nicotine pouch cans recorded in Americas segment, financial impact recorded in EA, AU & PMI GTR
segment. No meaningful U.S. travel retail volumes in prior year. Refer to additional information section of this release for shipments in pouch or pouch
equivalents. "-" indicates volume below 0.1 million cans
- 9 -

-- 9 of 17 --

Total PMI
• Estimated industry volume (excluding China and the U.S.) for cigarettes and HTUs was broadly stable,
with a 1.1% decrease for cigarettes, largely offset by 10.2% growth of HTUs.
• PMI's shipment volume increased by 1.4% with smoke-free volumes up by 12.8%. All SFP categories
grew strongly, and cigarette volume declined by 1.5%.
• Net revenues increased organically by 6.5%, mainly reflecting: a favorable pricing variance due to higher
combustible tobacco pricing; and favorable volume/mix, driven by higher SFP volume, notwithstanding
unfavorable mix and lower volumes for cigarettes.
• Adjusted operating income increased by 10.6% organically, reflecting: the same factors as for net
revenues; partly offset by marketing, administration and research costs.
Europe
• PMI's shipment volume decreased by 1.0% with cigarettes down by 5.5% and SFP up by 10.9%.
• Net revenues increased organically by 6.8%, reflecting: a favorable price variance, predominantly due to
higher combustible tobacco pricing; and favorable volume/mix, driven by higher SFP volume,
notwithstanding lower volumes and unfavorable mix for cigarettes. Our Aspeya wellness business also
grew organic net revenues strongly.
• Adjusted operating income increased by 8.5% on an organic basis, primarily reflecting: the same factors
as for net revenues; partly offset by higher marketing, administration and research costs.
SSEA, CIS & MEA
• PMI's shipment volume increased by 1.7% with SFP up by 14.1% and cigarettes up by 0.7%.
• Net revenues increased organically by 6.4%, mainly reflecting: a favorable price variance, predominantly
driven by combustible tobacco pricing; while unfavorable cigarette mix, due to the commercial model
change in Indonesia, was largely offset by higher cigarette and SFP volume.
• Adjusted operating income increased by 18.6% on an organic basis, mainly reflecting: a favorable price
variance as well as higher cigarette and SFP volume, partly offset by higher marketing, administration
and research costs as well as manufacturing costs (notably tobacco leaf).
East Asia, Australia & PMI Global Travel Retail
• PMI's shipment volume increased by 4.1% with SFP up by 11.0% and cigarettes down by 4.1%.
• Net revenues increased 4.6% organically, predominantly due to: favorable volume/mix, driven by SFP
volume; coupled with favorable price variance, driven by higher combustible tobacco pricing.
• Adjusted operating income increased 11.7% organically, reflecting the same factors as for net revenues.
Americas
• PMI's shipment volume increased by 3.1% with SFP up by 27.7% and cigarettes down by 1.7%.
• Net revenues increased 8.8% organically with favorable volume/mix, driven by SFP volume, and an
unfavorable U.S. price variance partly offset by cigarette pricing outside of the U.S.
• Adjusted OI decreased by 1.4% organically, reflecting the same factors as for net revenues, more than
offset by higher marketing, administration and research costs as well as manufacturing costs.
- 10 -

-- 10 of 17 --

Additional Information
Fourth-Quarter Full-Year
2025 2024 2025 2024
$ 1.37 $ (0.38) Reported Diluted EPS $ 7.26 $ 4.52
0.01 0.01 Restructuring charges 0.14 0.10
— — Impairment of goodwill and other intangibles 0.03 0.01
0.13 0.11 Amortization of intangibles 0.50 0.40
— 1.49 Impairment related to the RBH equity investment — 1.49
— 0.05 Megapolis localization tax impact — 0.05
(0.01) 0.14 Income tax impact associated with Swedish Match AB
financing (0.25) 0.14
— — Egypt sales tax charge — 0.03
— — Loss on sale of Vectura Group — 0.13
0.06 — Loss on expected sale of consumer accessories and
other businesses 0.06 —
— — Germany excise tax classification litigation charge 0.10 —
— — RBH (Canada) Plan Implementation, including dividend
income, net (0.10) —
— — Impairment of Wellness business related equity
investment 0.09 —
0.14 0.13 Fair value adjustment for equity security investments (0.18) (0.27)
— — Tax items (0.11) (0.03)
$ 1.70 $ 1.55 Adjusted Diluted EPS $ 7.54 $ 6.57
0.01 Less: Currency 0.04
$ 1.69 $ 1.55 Adjusted Diluted EPS, excluding Currency $ 7.50 $ 6.57
Fourth-Quarter
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2025 2024 Total
Excl.
Curr. &
Acq./
Div.
Total Cur-
rency Acq.
/ Div. Price Vol/
Mix Cost/
Other
(in millions)
Net Revenues $ 10,362 $ 9,706 6.8% 3.7% 656 345 (44) 285 73 (3)
Cost of Sales(1) (3,560) (3,423) (4.0)% (1.0)% (137) (131) 27 — 2 (35)
Marketing, Administration
and Research Costs(2) (3,429) (3,024) (13.4)% (8.3)% (405) (174) 20 — — (251)
Operating Income $ 3,373 $ 3,259 3.5% 2.2% 114 40 3 285 75 (289)
Restructuring charges 2 (12) +100% +100% 14 — — — — 14
Amortization of
intangibles (257) (247) (4.0)% (4.0)% (10) — — — — (10)
Loss on sale of Vectura
Group — (1) +100% +100% 1 — — — — 1
Loss on expected sale of
consumer accessories
and other businesses (94) — —% —% (94) — — — — (94)
Adjusted Operating
Income $ 3,722 $ 3,519 5.8% 4.5% 203 40 3 285 75 (200)
Adjusted Operating
Income Margin 35.9 % 36.3 % (0.4)pp 0.3pp
(1) Includes $6 million in 2025 and $5 million in 2024 related to the special items below.
(2) Includes $343 million in 2025 and $255 million in 2024 related to the special items below.
- 11 -

-- 11 of 17 --

Full-Year
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2025 2024 Total
Excl.
Curr. &
Acq./
Div.
Total Cur-
rency Acq.
/ Div. Price Vol/
Mix Cost/
Other
(in millions)
Net Revenues $ 40,648 $ 37,878 7.3 % 6.5 % 2,770 461 (170) 1,536 920 23
Cost of Sales (1) (13,366) (13,329) (0.3) % — % (37) (194) 155 — 164 (162)
Marketing, Administration
and Research Costs (2) (12,349) (11,147) (10.8) % (10.7) % (1,202) (113) 102 — — (1,191)
Impairment of Goodwill (41) — — % — % (41) — — — — (41)
Operating Income $ 14,892 $ 13,402 11.1 % 9.3 % 1,490 154 87 1,536 1,084 (1,371)
Restructuring charges (241) (180) (33.9) % (33.9) % (61) — — — — (61)
Impairment of goodwill
and other intangibles (41) (27) (51.9) % -(100)% (14) — 26 — — (40)
Amortization of
intangibles (1,003) (835) (20.1) % (23.7) % (168) — 30 — — (198)
Loss on sale of Vectura
Group — (199) +100% +100% 199 — — — — 199
Egypt sales tax charge — (45) +100% +100% 45 — — — — 45
Germany excise tax
classification litigation
charge
(176) — — % — % (176) — — — — (176)
RBH (Canada) Plan
implementation 19 — — % — % 19 — — — — 19
Loss on expected sale of
consumer accessories
and other businesses
(94) — — % — % (94) — — — — (94)
Adjusted Operating
Income $ 16,428 $ 14,688 11.8 % 10.6 % 1,740 154 31 1,536 1,084 (1,065)
Adjusted Operating
Income Margin 40.4 % 38.8 % 1.6pp 1.4pp
(1) Includes $22 million in 2025 and $51 million in 2024 related to the special items below.
(2) Includes $1,473 million in 2025 and $1,235 million in 2024 related to the special items below.
Note: Acq. / Div. variances predominantly due to the sale of Vectura Group Ltd. announced in September 2024
Fourth-Quarter Full-Year
2025 2024 Change
(pp) 2025 2024 Change
(pp)
Total International Market Share(1) 29.1 % 29.2 % (0.1) 29.2 % 29.0 % 0.2
Cigarettes 23.1 % 23.7 % (0.6) 23.4 % 23.7 % (0.3)
HTU 6.1 % 5.5 % 0.6 5.8 % 5.3 % 0.5
Cigarette over Cigarette Market Share(2) 25.1 % 25.6 % (0.5) 25.3 % 25.5 % (0.2)
(1) Defined as PMI's cigarette and heated tobacco unit IMS volume as a percentage of total industry cigarette and heated tobacco unit sales volume, excluding
China and the U.S., including cigarillos in Japan
(2) Defined as PMI's cigarette IMS volume as a percentage of total industry cigarette sales volume, excluding China and the U.S., including cigarillos in Japan
Note: Sum of share of market by product categories might not foot to total due to rounding.
- 12 -

-- 12 of 17 --

Fourth-Quarter
Oral SFP Shipments
(m pouch or pouch equivalents)4
Total PMI Europe SSEA, CIS &
MEA EA, AU &
PMI GTR Americas
Nicotine Pouches 3,341 240 111 20 2,970
vs. Q4 2024 17.2% (13.8)% 59.1% (23.4)% 19.9%
Snus 1,096 1,022 — 62 12
vs. Q4 2024 (11.0)% (15.8)% — — (32.6)%
Moist Snuff 523 — — — 523
vs. Q4 2024 (2.4)% — — — (2.4)%
Other Oral SFP 14 14 — — —
vs. Q4 2024 (23.6)% (23.6)% — — —
Total 4,974 1,276 111 82 3,505
vs. Q4 2024 7.3% (15.6)% 59.1% +100% 15.7%
Note: U.S. travel retail volumes of approximately 56m nicotine pouches recorded in Americas segment, financial impact recorded in EA, AU & PMI GTR
segment. No meaningful U.S. travel retail volumes in prior year. Refer to quarterly operating review section of this release for shipments in cans. "-" indicates
volume below 1 million pouch or pouch equivalents
4
Full-Year
Oral SFP Shipments
(m pouch or pouch equivalents)4
Total PMI Europe SSEA, CIS &
MEA EA, AU &
PMI GTR Americas
Nicotine Pouches 13,599 1,112 423 95 11,969
vs. FY 2024 36.0% 9.4% 98.4% 98.4% 37.2%
Snus 4,813 4,467 — 288 58
vs. FY 2024 (5.5)% (11.1)% — — (18.1)%
Moist Snuff 2,182 — — — 2,182
vs. FY 2024 (3.5)% — — — (3.5)%
Other Oral SFP 74 73 — — —
vs. FY 2024 (20.6)% (21.1)% — — —
Total 20,668 5,652 423 383 14,209
vs. FY 2024 18.5% (7.8)% 98.4% +100% 28.6%
Note: U.S. travel retail volumes of approximately 178m nicotine pouches recorded in Americas segment, financial impact recorded in EA, AU & PMI GTR
segment. No meaningful U.S. travel retail volumes in prior year. Refer to full-year operating review section of this release for shipments in cans. "-" indicates
volume below 1 million pouch or pouch equivalents
- 13 -
4 Oral smoke-free products conversion: (i) nicotine pouches (units): 15 pouches per can in the U.S. and approximately 20 pouches per can outside the U.S.; (ii)
snus products: weighted average 21 pouches equivalent per can; (iii) moist snuff products: weighted average 17 pouches equivalent per can; (iv) tobacco bits
products: weighted average 30 pouches equivalent per can; (v) chew bags products: weighted average 20 pouches per can.

-- 13 of 17 --

Philip Morris International: A Global Smoke-Free Champion
Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free
future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector.
The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-
not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105
markets, and as of December 31, 2025 PMI estimates they were used by over 43 million legal-age consumers
around the world, many of whom have moved away from cigarettes or significantly reduced their consumption.
The smoke-free business accounted for 41.5% of PMI’s full year 2025 total net revenues. Since 2008, PMI has
invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free
products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of
cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of
pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a
robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish
Match’s General snus and ZYN nicotine pouches and versions of PMI’s IQOS devices and consumables - the
first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and
General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a
strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness
areas. References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., and its subsidiaries. For
more information, please visit www.pmi.com and www.pmiscience.com.
Forward-Looking and Cautionary Statements
This press release contains projections of future results and goals and other forward-looking statements,
including statements regarding expected financial or operational performance; capital allocation plans;
investment strategies; regulatory outcomes; market expectations; business plans and strategies. Achievement of
future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties
materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those
contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities
Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could
cause actual results and outcomes to differ materially from those contained in any forward-looking statements
made by PMI.
PMI's business risks include: marketing and regulatory restrictions that could reduce our competitiveness, disrupt
our SFP commercialization efforts, eliminate our ability to communicate with adult consumers, or ban certain of
our products in certain markets or countries; excise tax increases and discriminatory tax structures; health
concerns relating to the use of tobacco and other nicotine-containing products; litigation related to tobacco and/
or nicotine products and intellectual property rights; intense competition; inability to anticipate changes in adult
consumer preferences; use and reliance on third-parties; the adverse effects of global and individual country
economic, regulatory and political developments, natural disasters and conflicts; geopolitical instability affecting
international trade; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker
behavior; continued decline of tax-paid cigarettes; lost revenues as a result of counterfeiting, contraband and
cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency
devaluations, sustained periods of elevated inflation, and limitations on the ability to repatriate funds; adverse
changes in applicable corporate tax laws; disruptions in the credit markets or changes to its credit ratings; recent
and potential future tariffs imposed by the U.S. and other countries; adverse changes in the cost, availability, and
- 14 -

-- 14 of 17 --

quality of tobacco and other agricultural products and raw materials, as well as product components for our
electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies.
PMI's future profitability may also be adversely affected should it be unsuccessful, in key markets or
systemically, in its efforts to introduce, commercialize, and grow smoke-free products or if regulation or taxation
do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products,
promote brand equity; if there are prolonged disruptions of facilities used to produce its products; if it is unable to
enter new markets or improve its margins through increased prices and productivity gains; if other market
participants are more successful in their SFP commercialization efforts; if it is unable to attract and retain the
best global talent; or if it is unable to successfully integrate and realize the expected benefits from recent
transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free
products performance.
PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's
Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2024, Quarterly Report on
Form 10-Q for the third quarter ended September 30, 2025, and the Form 10-K for the fourth quarter and year
ended December 31, 2025, which will be filed later today. PMI cautions that the foregoing list of important factors
is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any
forward-looking statement that it may make from time to time, except in the normal course of its public disclosure
obligations.
Non-GAAP Measures, Glossary and Explanatory Notes
Reconciliations of non-GAAP measures in this release to the most directly comparable U.S. GAAP measures
can be found in Exhibit 99.2 to the Form 8-K dated February 6, 2026, and here. A glossary of key terms,
definitions and explanatory notes is available in the aforementioned Exhibit 99.2 and on the same webpage,
where additional financial schedules, as well as adjustments and other calculations have also been made
available.
Management reviews net revenues, gross profit, operating income, operating income margin, operating cash
flow and earnings per share, or "EPS," on an adjusted basis, which may exclude the impact of currency and
other items such as acquisitions, divestitures, restructuring costs, tax items and other special items. Additionally,
starting in 2022 and on a comparative basis, for these measures other than net revenues and operating cash
flow, PMI includes adjustments to add back amortization expense on acquisition related intangible assets that
are recorded as part of purchase accounting and contribute to PMI’s revenue generation, as well as impairment
of intangible assets, if any. While amortization expense on acquisition related intangible assets is excluded in
these adjusted measures, the net revenues generated from these acquired intangible assets are included in the
company's adjusted measures, unless otherwise stated. Currency-neutral and organic growth rates reflect the
way management views underlying performance for these measures. PMI believes that such measures provide
useful insight into underlying business trends and results. Management reviews these measures because they
exclude changes in currency exchange rates and other factors that may distort underlying business trends,
thereby improving the comparability of PMI’s business performance between reporting periods. Furthermore,
PMI uses several of these measures in its management compensation program to promote internal fairness and
a disciplined assessment of performance against company targets. PMI discloses these measures to enable
investors to view the business through the eyes of management.
Non-GAAP measures used in this release should neither be considered in isolation nor as a substitute for the
financial measures prepared in accordance with U.S. GAAP.
- 15 -

-- 15 of 17 --

Appendix 1
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Key Market Data
Fourth-Quarter
Market
Cigarette & HTU
Industry Vol. (bn units)
PMI Shipments (bn units) PMI Volume Share(2) (%)
Cigarette & HTU Cigarette HTU Cigarette & HTU HTU
2025 2024 %
Change 2025 2024 %
Change 2025 2024 %
Change 2025 2024 %
Change 2025 2024 pp
Change 2025 2024 pp
Change
Total(1)(2) 656.9 656.5 0.1 187.8 188.5 (0.4) 149.4 152.8 (2.2) 38.4 35.7 7.5 29.1 29.2 (0.1) 6.1 5.5 0.6
Europe
France 5.7 6.3 (9.4) 2.4 2.4 1.7 2.4 2.4 2.1 — — — 40.7 41.8 (1.1) 0.5 0.6 (0.1)
Germany(3) 16.5 16.2 1.7 6.7 6.6 1.3 5.4 5.4 (1.3) 1.3 1.1 13.5 37.4 38.4 (1.0) 7.7 6.6 1.1
Italy(3) 18.1 17.9 1.1 10.7 10.1 6.1 6.0 6.4 (5.4) 4.7 3.7 25.7 53.9 53.1 0.8 20.1 16.5 3.6
Poland(3) 11.5 13.6 (15.4) 5.4 6.2 (12.5) 4.2 4.8 (11.9) 1.2 1.4 (14.4) 46.8 45.5 1.3 10.9 9.7 1.2
Spain 10.8 11.1 (2.4) 3.2 2.8 14.3 2.9 2.5 16.7 0.4 0.4 (0.8) 30.1 29.6 0.5 3.8 3.5 0.3
SSEA, CIS & MEA
Egypt 23.1 22.5 2.5 6.5 5.4 21.2 6.1 4.9 24.1 0.4 0.5 (10.5) 29.1 24.5 4.6 1.8 1.7 0.1
Indonesia(4) 66.4 65.5 1.4 20.0 20.3 (1.6) 19.5 19.9 (1.9) 0.4 0.4 17.1 30.1 31.0 (0.9) 0.6 0.6 —
Philippines 11.8 11.2 4.7 5.5 5.3 5.3 5.4 5.2 4.4 0.1 0.1 61.0 47.0 46.8 0.2 1.1 0.7 0.4
Russia 56.3 54.8 2.9 16.7 18.0 (7.1) 10.9 12.5 (12.7) 5.8 5.5 5.7 31.1 32.9 (1.8) 9.8 8.7 1.1
Turkey 40.3 38.6 4.6 18.8 20.4 (7.9) 18.8 20.4 (7.9) — — — 46.4 52.9 (6.5) — — —
EA, AU & PMI GTR
Australia 0.5 1.1 (60.6) 0.2 0.4 (50.3) 0.2 0.4 (50.3) — — — 37.1 31.3 5.8 — — —
Japan(2)(3) 38.5 38.8 (1.0) 13.3 13.7 (3.0) 3.4 3.9 (12.1) 9.8 9.8 0.7 43.3 41.9 1.4 32.6 30.6 2.0
South Korea 16.2 17.6 (8.0) 3.3 3.4 (2.3) 1.7 2.0 (11.8) 1.6 1.4 10.5 20.7 19.5 1.2 9.9 8.2 1.7
Americas
Argentina 6.9 7.2 (4.0) 4.4 4.5 (2.8) 4.4 4.5 (2.8) — — — 63.3 62.5 0.8 — — —
Mexico 9.7 9.6 0.8 5.6 5.6 — 5.5 5.5 (0.8) 0.1 0.1 82.3 57.8 58.2 (0.4) 1.1 0.6 0.5
(1) Market share estimates are calculated using IMS data, unless otherwise stated. Depending on the market and distribution model, IMS may represent an estimate. Consequently, past reported periods may be updated to ensure comparability and to
incorporate the most current information.
(2) Total industry and volume share estimates include cigarillos in Japan
(3) PMI market share reflects estimated adjusted IMS volume share (see Glossary for definition); Total Market is based on reported IMS
(4) 2025 includes 2.3 billion units and 2024 includes 0.6 billion units of cigarette shipment volume under an arrangement where PMI acts as brand management and fulfilment services agent
Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%

-- 16 of 17 --

Appendix 2
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Key Market Data
Full-Year
Market
Cigarette & HTU
Industry Vol. (bn units)
PMI Shipments (bn units) PMI Volume Share(2) (%)
Cigarette & HTU Cigarette HTU Cigarette & HTU HTU
2025 2024 %
Change 2025 2024 %
Change 2025 2024 %
Change 2025 2024 %
Change 2025 2024 pp
Change 2025 2024 pp
Change
Total(1)(2) 2,586.9 2,596.0 (0.4) 762.5 756.6 0.8 607.4 616.8 (1.5) 155.1 139.7 11.0 29.2 29.0 0.2 5.8 5.3 0.5
Europe
France 23.8 26.1 (8.8) 9.9 10.7 (7.9) 9.7 10.5 (7.6) 0.1 0.2 (29.6) 40.3 41.2 (0.9) 0.5 0.6 (0.1)
Germany(3) 69.3 69.2 0.1 26.2 26.7 (2.0) 21.3 22.4 (5.1) 4.9 4.3 14.6 37.5 38.6 (1.1) 7.2 6.2 1.0
Italy(3) 73.9 73.6 0.4 40.3 39.1 3.1 25.7 27.3 (5.9) 14.6 11.8 23.7 53.6 53.6 — 18.6 16.9 1.7
Poland(3) 51.0 58.0 (12.1) 23.2 25.6 (9.4) 18.2 20.1 (9.9) 5.0 5.4 (7.7) 45.3 43.8 1.5 10.0 9.2 0.8
Spain 43.6 44.4 (1.7) 13.3 12.7 4.9 11.9 11.4 4.1 1.4 1.3 11.9 29.6 29.3 0.3 3.4 2.9 0.5
SSEA, CIS & MEA
Egypt 87.3 82.8 5.5 26.0 23.9 8.9 24.6 22.3 10.1 1.4 1.6 (7.5) 30.0 28.8 1.2 1.9 1.8 0.1
Indonesia(4) 258.7 265.2 (2.4) 79.4 80.8 (1.8) 77.9 79.6 (2.2) 1.5 1.2 23.2 30.7 30.5 0.2 0.6 0.5 0.1
Philippines 46.4 44.9 3.4 22.0 21.1 4.3 21.5 20.8 3.6 0.5 0.3 58.1 47.3 46.9 0.4 1.0 0.7 0.3
Russia 220.6 216.5 1.9 69.8 69.9 (0.1) 49.5 51.4 (3.8) 20.3 18.5 9.9 31.7 32.3 (0.6) 9.3 8.6 0.7
Turkey 160.2 150.5 6.4 74.3 78.2 (4.9) 74.3 78.2 (4.9) — — — 46.4 52.0 (5.6) — — —
EA, AU & PMI GTR
Australia 2.8 5.1 (45.7) 1.0 1.8 (45.2) 1.0 1.8 (45.2) — — — 35.4 34.8 0.6 — — —
Japan(2)(3) 150.6 151.1 (0.3) 67.8 64.8 4.7 15.9 16.5 (3.8) 52.0 48.3 7.5 43.0 41.4 1.6 32.1 29.9 2.2
South Korea 68.0 70.5 (3.5) 14.0 14.0 (0.1) 7.5 8.3 (9.3) 6.5 5.7 13.2 20.6 19.9 0.7 9.5 8.1 1.4
Americas
Argentina 26.8 26.4 1.8 17.0 16.4 4.1 17.0 16.4 4.1 — — — 63.5 62.1 1.4 — — —
Mexico 30.5 31.6 (3.6) 17.6 18.5 (4.8) 17.3 18.3 (5.3) 0.3 0.2 43.2 57.8 58.5 (0.7) 1.0 0.7 0.3
(1) Market share estimates are calculated using IMS data, unless otherwise stated. Depending on the market and distribution model, IMS may represent an estimate. Consequently, past reported periods may be updated to ensure comparability and to
incorporate the most current information.
(2) Total industry and volume share estimates include cigarillos in Japan
(3) PMI market share reflects estimated adjusted IMS volume share (see Glossary for definition); Total Market is based on reported IMS
(4) 2025 includes 8.7 billion units and 2024 includes 0.6 billion units of cigarette shipment volume under an arrangement where PMI acts as brand management and fulfilment services agent
Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%

-- 17 of 17 --